Literature DB >> 21722078

Measurement of plasma amino acids by Ultraperformance® Liquid Chromatography.

Srinivas B Narayan1, Gail Ditewig-Meyers, Kendon S Graham, Robert Scott, Michael J Bennett.   

Abstract

BACKGROUND: Since the early 1960s, quantitative amino acid analysis (AAA) has traditionally been performed using ion-exchange chromatography with post-column ninhydrin derivatization. This established technology has many advantages, including relatively low cost of operation and ease of use. However, analysis times of 120+ min and high maintenance requirements make this technology unsuitable for the modern clinical laboratories with a requirement for rapid turnaround times. The work described here is a summary of our experiences with a new approach to full profile analysis of physiological amino acids.
METHODS: Amino acids were derivatized in batches with a proprietary reagent, AccQTag®, which reacts with primary and secondary amines. The derivatized amino acids were separated using Ultraperformance® Liquid Chromatography (UPLC). In a prospective method comparison, quantitative plasma amino acid data obtained from approximately 170 patient samples using both the UPLC method and a traditional ion-exchange chromatography amino acid analyzer were evaluated.
RESULTS: The data obtained from the two methods were found to agree well. Correlation coefficients for the most important amino acids seen in inborn errors of metabolism, such as phenylalanine, tyrosine and branched chain amino acids varied from 0.8658 to 0.9932 with minor slope biases. This approach also reduced the run time from 120 to 45 min per sample using a sample volume of 0.1 mL, compared to the 0.5 mL volume required for ion-exchange chromatography.
CONCLUSIONS: This new approach for the full profile analysis of physiological amino acids has been shown to be a viable substitute for current ion-exchange methodologies. It provides substantial benefits including significant reductions in runtime and necessary sample volume for the investigation and monitoring of patients with metabolic disorders and for nutritional management of a variety of patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21722078     DOI: 10.1515/CCLM.2011.200

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  10 in total

1.  Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes.

Authors:  Cristina Hernández; Patricia Bogdanov; Cristina Solà-Adell; Joel Sampedro; Marta Valeri; Xavier Genís; Olga Simó-Servat; Marta García-Ramírez; Rafael Simó
Journal:  Diabetologia       Date:  2017-08-04       Impact factor: 10.122

2.  Propionyl-CoA carboxylase pcca-1 and pccb-1 gene deletions in Caenorhabditis elegans globally impair mitochondrial energy metabolism.

Authors:  Kimberly A Chapman; Julian Ostrovsky; Meera Rao; Stephen D Dingley; Erzsebet Polyak; Marc Yudkoff; Rui Xiao; Michael J Bennett; Marni J Falk
Journal:  J Inherit Metab Dis       Date:  2017-11-20       Impact factor: 4.982

3.  Short-chain 3-hydroxyacyl-coenzyme A dehydrogenase associates with a protein super-complex integrating multiple metabolic pathways.

Authors:  Srinivas B Narayan; Stephen R Master; Anthony N Sireci; Charlene Bierl; Paige E Stanley; Changhong Li; Charles A Stanley; Michael J Bennett
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

4.  Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patients.

Authors:  Meritxell Ventura-Cots; Mar Concepción; José Antonio Arranz; Macarena Simón-Talero; Maria Torrens; Albert Blanco-Grau; Inma Fuentes; Pilar Suñé; Edilmar Alvarado-Tapias; Cristina Gely; Eva Roman; Beatriz Mínguez; German Soriano; Joan Genescà; Juan Córdoba
Journal:  Therap Adv Gastroenterol       Date:  2016-07-26       Impact factor: 4.409

Review 5.  Why Not Glycine Electrochemical Biosensors?

Authors:  Clara Pérez-Ràfols; Yujie Liu; Qianyu Wang; María Cuartero; Gastón A Crespo
Journal:  Sensors (Basel)       Date:  2020-07-21       Impact factor: 3.576

6.  Effects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration.

Authors:  Patricia Bogdanov; Joel Sampedro; Cristina Solà-Adell; Olga Simó-Servat; Carla Russo; Luisa Varela-Sende; Rafael Simó; Cristina Hernández
Journal:  Int J Mol Sci       Date:  2018-08-20       Impact factor: 5.923

7.  Quantitative amino acid analysis by liquid chromatography-tandem mass spectrometry using low cost derivatization and an automated liquid handler.

Authors:  William S Phipps; Eric Crossley; Richard Boriack; Patricia M Jones; Khushbu Patel
Journal:  JIMD Rep       Date:  2019-11-12

8.  Plasma amino acid profiling improves predictive accuracy of adverse events in patients with heart failure.

Authors:  Hidemichi Kouzu; Satoshi Katano; Toshiyuki Yano; Katsuhiko Ohori; Ryohei Nagaoka; Takuya Inoue; Yuhei Takamura; Tomoyuki Ishigo; Ayako Watanabe; Masayuki Koyama; Nobutaka Nagano; Takefumi Fujito; Ryo Nishikawa; Wataru Ohwada; Tetsuji Miura
Journal:  ESC Heart Fail       Date:  2021-09-06

9.  Brain-blood amino acid correlates following protein restriction in murine maple syrup urine disease.

Authors:  Kara R Vogel; Erland Arning; Brandi L Wasek; Sterling McPherson; Teodoro Bottiglieri; K Michael Gibson
Journal:  Orphanet J Rare Dis       Date:  2014-05-08       Impact factor: 4.123

10.  Metabolomic analysis of obesity, metabolic syndrome, and type 2 diabetes: amino acid and acylcarnitine levels change along a spectrum of metabolic wellness.

Authors:  Diane M Libert; Amy S Nowacki; Marvin R Natowicz
Journal:  PeerJ       Date:  2018-08-31       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.